Advanced oxidation of real sulfamethoxazole + trimethoprim formulations using different anodes and electrolytes

dc.contributor.authorMurillo Sierra, Juan C.
dc.contributor.authorSirés Sadornil, Ignacio
dc.contributor.authorBrillas, Enric
dc.contributor.authorRuiz Ruiz, Edgar J.
dc.contributor.authorHernández Ramírez, Aracely
dc.date.accessioned2020-03-13T10:04:33Z
dc.date.available2020-03-13T10:04:33Z
dc.date.issued2018-02
dc.date.updated2020-03-13T10:04:33Z
dc.description.abstractA commercial sulfamethoxazole + trimethoprim formulation has been degraded in 0.050 M Na2SO4 at pH 3.0 by electrochemical oxidation with electrogenerated H2O2 (EO-H2O2), electro-Fenton (EF), photoelectro-Fenton with a 6-W UVA lamp (PEF) and solar photoelectro-Fenton (SPEF). The tests were performed in an undivided cell with an IrO2-based, Pt or boron-doped diamond (BDD) anode and an air-diffusion cathode for H2O2 electrogeneration. The anode material had little effect on the accumulated H2O2 concentration. Both drugs always obeyed a pseudo-first-order decay with low apparent rate constant in EO-H2O2. Much higher values were found in EF, PEF and SPEF, showing no difference because the main oxidant was always ¿OH formed from Fenton's reaction between H2O2 and added Fe2+. The solution mineralization increased in the sequence EO-H2O2 < EF < PEF < SPEF regardless of the anode. The IrO2-based and Pt anodes behaved similarly but BDD was always more powerful. In SPEF, similar mineralization profiles were found for all anodes because of the rapid removal of photoactive intermediates by sunlight. About 87% mineralization was obtained as maximum for the powerful SPEF with BDD anode. Addition of Cl- enhanced the decay of both drugs due to their quicker reaction with generated active chlorine, but the formation of persistent chloroderivatives decelerated the mineralization process. Final carboxylic acids like oxalic and oxamic were detected, yielding Fe(III) complexes that remained stable in EF with BDD but were rapidly photolyzed in SPEF with BDD, explaining its superior mineralization ability.
dc.format.extent9 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec674123
dc.identifier.issn0045-6535
dc.identifier.urihttps://hdl.handle.net/2445/152682
dc.language.isoeng
dc.publisherElsevier Ltd
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.1016/j.chemosphere.2017.10.136
dc.relation.ispartofChemosphere, 2018, vol. 192, p. 225-233
dc.relation.urihttps://doi.org/10.1016/j.chemosphere.2017.10.136
dc.rightscc-by-nc-nd (c) Elsevier Ltd, 2018
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es
dc.sourceArticles publicats en revistes (Ciència dels Materials i Química Física)
dc.subject.classificationOxidació electroquímica
dc.subject.classificationFormulació clínica
dc.subject.classificationEstabilitat dels medicaments
dc.subject.otherElectrolytic oxidation
dc.subject.otherCase formulation
dc.subject.otherDrug stability
dc.titleAdvanced oxidation of real sulfamethoxazole + trimethoprim formulations using different anodes and electrolytes
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/acceptedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
674123.pdf
Mida:
182.89 KB
Format:
Adobe Portable Document Format